DRUG RECOVERY CENTRE — PHUKET, THAILAND
Amphetamine Addiction
A clinical guide to amphetamine addiction, including both prescription and illicit amphetamines, the neuroscience of stimulant dependence, and structured treatment pathways at Phuket Island Rehab.
Table of Contents
What Is Amphetamine Addiction?
Amphetamine addiction, clinically classified as amphetamine-type stimulant use disorder, is a pattern of compulsive amphetamine use characterised by loss of control, continued use despite harm, and physiological adaptation including tolerance and withdrawal. The amphetamine class includes prescription medications (dexamphetamine, lisdexamfetamine/Vyvanse, Adderall) and illicit forms (speed, paste/base, and the more potent methamphetamine).
Amphetamines work by increasing synaptic concentrations of dopamine, norepinephrine, and serotonin through multiple mechanisms: they reverse monoamine transporters (DAT, NET, SERT), inhibit vesicular monoamine transporter 2 (VMAT2), and weakly inhibit monoamine oxidase. The resulting catecholamine surge produces enhanced alertness, energy, confidence, and euphoria.
The United Nations Office on Drugs and Crime estimates that approximately 34 million people used amphetamine-type stimulants globally in the past year, with the Asia-Pacific region accounting for the largest share of global use. Thailand and neighbouring countries face particular challenges with amphetamine availability, making treatment services in the region critically important.
How Amphetamine Addiction Develops
The progression to amphetamine addiction follows the classic dopaminergic reward hijacking pathway, with the speed of progression influenced by dose, route of administration, and frequency of use.
Reinforcement: Amphetamines produce dopamine release 3-10 times greater than natural rewards. This magnitude of dopaminergic signalling creates powerful associative learning that links amphetamine use with enhanced performance, pleasure, or coping. Faster routes of administration (smoking, injecting) produce more intense reinforcement and faster addiction development.
Tolerance: Repeated exposure triggers compensatory downregulation of dopamine receptors (particularly D2 receptors) and reduced endogenous dopamine production. PET imaging studies demonstrate measurable D2 receptor reductions within 2-4 weeks of daily use, with reductions of 15-25 percent common in chronic users.
Dependence and withdrawal: The adapted dopamine system becomes reliant on amphetamine to maintain even baseline function. Cessation triggers a withdrawal syndrome characterised by severe fatigue, hypersomnia, increased appetite, psychomotor retardation, depression, and anhedonia. While not medically dangerous, the profound dysphoria of amphetamine withdrawal powerfully drives relapse.
Types of Amphetamines and Their Risks
| Type | Common Forms | Route | Addiction Risk |
|---|---|---|---|
| Prescription amphetamine | Dexamphetamine, Adderall, Vyvanse | Oral (designed for slow release) | Moderate (higher if crushed/snorted) |
| Illicit amphetamine (speed) | Powder, paste/base | Snorted, oral, injected | High (variable purity, unknown adulterants) |
| Methamphetamine | Crystal meth, ice, yaba tablets | Smoked, injected, oral | Very high (more potent, longer-acting, more neurotoxic) |
| Captagon | Fenethylline tablets (Middle East) | Oral | High (prodrug converted to amphetamine and theophylline) |
Health Consequences of Chronic Amphetamine Use
Beyond the neurological effects of dopamine system adaptation, chronic amphetamine use produces widespread systemic damage. Cardiovascular effects include chronic hypertension, accelerated atherosclerosis, and cardiomyopathy from sustained sympathetic activation. Dental deterioration (“meth mouth”) results from xerostomia, bruxism, and poor nutritional status. Weight loss and malnutrition are common due to chronic appetite suppression. Psychiatric effects include persistent anxiety, insomnia, paranoia, and in severe cases, a chronic psychotic state that can persist months after cessation.
Cognitive effects are measurable on neuropsychological testing, with deficits in attention, working memory, executive function, and impulse control. The good news is that substantial cognitive recovery occurs with sustained abstinence, with most deficits showing significant improvement by 12-18 months.
Treatment for Amphetamine Addiction
There are currently no FDA-approved medications specifically for amphetamine use disorder, making psychosocial interventions the cornerstone of treatment.
Withdrawal management: The “crash” phase (days 1-5) requires rest, nutritional support, and symptomatic relief. Medications may include mirtazapine for sleep and mood, modafinil for residual fatigue (used cautiously), and N-acetylcysteine for glutamate modulation and craving reduction. The protracted withdrawal phase of anhedonia and low motivation can last weeks to months and requires ongoing support.
Psychotherapy: Cognitive-Behavioural Therapy and Contingency Management have the strongest evidence base for stimulant use disorders. CBT targets the cognitive distortions sustaining use, while Contingency Management uses structured reward systems to reinforce abstinence. Motivational interviewing addresses ambivalence, and trauma-informed care is essential given the high prevalence of co-occurring PTSD in stimulant-dependent populations.
Lifestyle rehabilitation: Structured exercise is a critical therapeutic tool in amphetamine recovery, directly supporting dopamine receptor recovery. Nutritional rehabilitation addresses the malnutrition common in chronic users. Sleep hygiene restoration and stress management training complete the foundation for sustained recovery.
When Substance Use Becomes More Than Occasional
Amphetamine use often begins functionally, whether for work performance, academic pressure, weight management, or occasional recreational use. The shift toward problematic use is marked by needing the drug to function at baseline rather than to enhance performance, using larger amounts or more frequently than intended, experiencing withdrawal symptoms (fatigue, depression) when not using, and continuing despite relationship, health, or work consequences.
“Recovery from amphetamine addiction requires patience because the dopamine system heals slowly. Patients need to understand that the flat, unmotivated feeling they experience in early recovery is temporary, not permanent. The brain rebuilds its natural reward capacity, but it takes months, not days. Our programme is designed to support people through that difficult transition.” — Dr. Ponlawat Pitsuwan
Frequently Asked Questions
Is amphetamine addiction the same as meth addiction?
Methamphetamine is a specific type of amphetamine, and the addiction mechanisms are fundamentally similar. However, methamphetamine is more potent, longer-acting, and more neurotoxic than standard amphetamine. Treatment approaches are largely the same, though methamphetamine users may require longer treatment durations and more intensive psychiatric support due to higher rates of psychosis and more severe neurotoxicity.
How long does recovery from amphetamine addiction take?
Acute withdrawal resolves within 1-2 weeks, but the post-acute withdrawal phase of anhedonia, low motivation, and cognitive recovery can last 2-6 months. Dopamine receptor density shows significant recovery by 12-18 months of abstinence. Most patients require ongoing support and relapse prevention for at least the first year.
Can the brain fully recover from amphetamine addiction?
Research is encouraging: PET imaging studies show substantial recovery of dopamine receptor density with sustained abstinence, and cognitive function improves significantly. Most functional recovery occurs within the first 12-18 months. While very heavy, prolonged use may leave some residual changes, the vast majority of patients can achieve excellent neurological recovery with proper treatment and sustained abstinence.
How does Phuket Island Rehab treat amphetamine addiction?
Our programme provides medically supervised withdrawal management followed by an intensive therapeutic programme combining CBT, contingency management, group therapy, physical fitness programming, and nutritional rehabilitation. Located in Phuket, we serve patients from across Asia and internationally, with particular experience treating the amphetamine use patterns prevalent in the region. Our residential programme provides the duration and intensity needed for meaningful dopamine system recovery.
Stimulant Addiction · Meth Addiction · Adderall Addiction · Cocaine Addiction · MDMA Addiction · Ketamine Addiction · GHB Addiction · Fentanyl Addiction · LSD Addiction · Prescription Drug Addiction · Medical Detox
Clinical Reviewer: Dr. Ponlawat Pitsuwan, Physician | Publisher: Phuket Island Rehab | Last Updated: April 2026 | Clinical Entities: Amphetamine-Type Stimulant Use Disorder, Dopamine Transporter (DAT) Reversal, D2 Receptor Downregulation, VMAT2, Dexamphetamine, Lisdexamfetamine, Stimulant-Induced Psychosis, Contingency Management, N-Acetylcysteine, Yaba